Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of once-daily tiotropium 18 mcg versus salmeterol in COPD
2007-001840-33Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tiotropium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Time to first COPD exacerbation. Started Aug 2007; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2007-001840-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001840-33.